Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2021Response to Dahl et al: Oral semaglutide improves postprandial glucose and lipid metabolism, and delays gastric emptying, in subjects with type 2 diabetesHorowitz, M.; Rayner, C.K.; Marathe, C.S.; Wu, T.; Umapathysivam, M.; Jones, K.L.
2020Glucagon‐like peptide‐1 receptor agonists and the appropriate measurement of gastric emptyingHorowitz, M.; Rayner, C.K.; Marathe, C.S.; Wu, T.; Jones, K.L.
2020Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight, subjects under steady-state concentrationsJones, K.L.; Huynh, L.Q.; Hatzinikolas, S.; Rigda, R.S.; Phillips, L.K.; Pham, H.T.; Marathe, C.S.; Wu, T.; Malbert, C.H.; Stevens, J.E.; Lange, K.; Rayner, C.K.; Horowitz, M.
2020Gastrointestinal autonomic neuropathy in diabetesMarathe, C.S.; Jones, K.L.; Wu, T.; Rayner, C.K.; Horowitz, M.
2019Effects of lixisenatide on postprandial blood pressure, gastric emptying and glycaemia in healthy people and people with type 2 diabetesJones, K.L.; Rigda, R.S.; Buttfield, M.D.M.; Hatzinikolas, S.; Pham, H.T.; Marathe, C.S.; Wu, T.; Lange, K.; Trahair, L.G.; Rayner, C.K.; Horowitz, M.
2022Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric EmptyingMarathe, C.S.; Pham, H.; Wu, T.; Trahair, L.G.; Rigda, R.S.; Buttfield, M.D.M.; Hatzinikolas, S.; Lange, K.; Rayner, C.K.; Mari, A.; Horowitz, M.; Jones, K.L.
2021Gastric emptying in health and type 2 diabetes: an evaluation using a 75g oral glucose drinkXie, C.; Huang, W.; Wang, X.; Trahair, L.G.; Pham, H.T.; Marathe, C.S.; Young, R.L.; Jones, K.L.; Horowitz, M.; Rayner, C.K.; Wu, T.
2021Spontaneous or deliberate: effects of acute variations in glycemia on gastric emptying in type 1 diabetesHorowitz, M.; Wu, T.; Rayner, C.K.; Marathe, C.S.; Jones, K.L.
2017Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetesThazhath, S.; Marathe, C.S.; Wu, T.; Chang, J.; Khoo, J.; Kuo, P.; Checklin, H.L.; Bound, M.J.; Rigda, R.S.; Horowitz, M.; Jones, K.L.; Rayner, C.K.